Results 331 to 340 of about 715,867 (372)

Minimal Hepatic Encephalopathy

Clinics in Liver Disease, 2020
Minimal hepatic encephalopathy, previously called subclinical hepatic encephalopathy, represents the earliest and mildest form of hepatic encephalopathy. It is the most under-recognized and underdiagnosed form of hepatic encephalopathy. Although there is no diagnostic gold standard, validated testing modalities have been devised to detect this ...
Briette Verken, Karanfilian, Taeyang, Park, Frank, Senatore, Vinod K, Rustgi   +3 more
openaire   +2 more sources

Hepatic Encephalopathy

Medical Clinics of North America, 1989
Hepatic encephalopathy (HE) is a complex reversible syndrome that can progress to coma. Recently, behavioral and electrophysiologic ameliorations of HE have been reported to occur in animal models of fulminant hepatic failure (FHF) and, in uncontrolled studies, in a majority of patients with FHF or cirrhosis following the intravenous administration of ...
S H, Gammal, E A, Jones
openaire   +2 more sources

Zinc deficiency predicts overt hepatic encephalopathy and mortality in liver cirrhosis patients with minimal hepatic encephalopathy

Hepatology Research, 2020
Minimal hepatic encephalopathy (MHE) is associated with poor outcomes and the development of overt hepatic encephalopathy (OHE) in patients with liver cirrhosis (LC).
T. Miwa, T. Hanai, Toshihide Maeda, Yui Ogiso, K. Imai, A. Suetsugu, Koji Takai, M. Shiraki, N. Katsumura, M. Shimizu   +9 more
semanticscholar   +1 more source

Hepatic Encephalopathy

2011
Hepatic encephalopathy (HE) is a neuropsychiatric syndrome which can develop in the course of chronic and acute liver disease. It is characterized by cognitive and motoric deficits of varying severity. HE is functional in nature, potentially reversible and is thought to reflect the clinical manifestation of a low-grade cerebral edema, which exacerbates
openaire   +4 more sources

Minimal hepatic encephalopathy

Indian Journal of Gastroenterology, 2009
Minimal hepatic encephalopathy (MHE) is the mildest form of spectrum of hepatic encephalopathy (HE). Patients with MHE have no recognizable clinical symptoms of HE but have mild cognitive and psychomotor deficits. The prevalence of MHE is high in patients with cirrhosis of liver and varies between 30% and 84%; it is higher in patients with poor liver ...
Radha K, Dhiman, Yogesh K, Chawla
openaire   +2 more sources

Lactulose improves cognition, quality of life, and gut microbiota in minimal hepatic encephalopathy: A multicenter, randomized controlled trial

Journal of Digestive Diseases, 2019
Lactulose is effective in the treatment and prevention of overt hepatic encephalopathy (OHE), but there are limited data on its use on microbiota in relations to minimal hepatic encephalopathy (MHE) recovery.
Ji Yao Wang, J. Bajaj, Jiang-bin Wang, J. Shang, Xinping Zhou, Xiao-lin Guo, Xuan Zhu, L. Meng, Hai-xing Jiang, Y. Mi, Jian-ming Xu, J. Yang, Bai-Song Wang, Ning-ping Zhang   +13 more
semanticscholar   +1 more source

Hepatic Encephalopathy

Neurologic Clinics, 2002
Many patients with cirrhosis of the liver who appear to be overtly normal, using standard bedside examination techniques, test in the impaired range on one or more neuropsychological tests. These impairments affect the quality of life. Improvement in affected cognitive domains and the quality of life may follow the institution of treatment.
openaire   +2 more sources

EASL Clinical Practice Guidelines on the management of hepatic encephalopathy.

Journal of Hepatology, 2022
S. Montagnese, M. Romero Gómez, F. Larsen, D. Shawcross, D. Thabut, Hendrik V. Arenstorff Vilstrup, K. Weissenborn, P. Rautou   +7 more
semanticscholar   +1 more source

Minimal hepatic encephalopathy

Nature Clinical Practice Gastroenterology & Hepatology, 2007
Minimal hepatic encephalopathy (MHE), formerly known as subclinical hepatic encephalopathy, is the mild cognitive impairment commonly seen in patients who have cirrhosis. Current understanding suggests that MHE forms part of the spectrum of hepatic encephalopathy, although this remains to be proven.
Charmaine A, Stewart, Glenn E, Smith
openaire   +2 more sources

Raised serum Interleukin‐6 identifies patients with liver cirrhosis at high risk for overt hepatic encephalopathy

Alimentary Pharmacology and Therapeutics, 2019
Systemic inflammation is a driving force for the development of hepatic encephalopathy and recent studies demonstrated that elevated Interleukin‐6 (IL‐6) serum levels are associated with the presence of minimal hepatic encephalopathy in patients with ...
C. Labenz, G. Toenges, Y. Huber, M. Nagel, J. Marquardt, J. Schattenberg, P. Galle, J. Labenz, M. Wörns   +8 more
semanticscholar   +1 more source